Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (131)	5/31/1998 9:18:00 PM
From: Anthony Wong	Respond to of 1722

American Home, Merck Are Good Bets Among Overpriced Drug Stocks Bloomberg News May 31, 1998, 4:48 p.m. PT American Home, Merck Are Good Bets Among Overpriced Drug Stocks New York, May 31 (Bloomberg) -- American Home Products Corp. is a favorite of Everen Securities Inc. chief investment strategist Rao Chalsani, who looks for bargains in what he considers overpriced sectors, Forbes magazine reported. Merck & Co. is another drug company that Chalsani likes, while he warns that Pfizer Inc. is one to avoid. Chalsani picks Qualcomm Inc. out of the expensive technology sector and predicts a 40 percent yearly growth rate for the company over the next five years, the magazine said. Earlier this month, American Home Products bought closely held Apollon Inc., a biotechnology company that's been working on DNA-based vaccines for herpes, hepatitis and the virus that causes AIDS. (Forbes 6/15 286, www.forbes.com) --Mary Guidry in the Princeton newsroom (609) 279-4028/jcn

To: Anthony Wong who wrote (131)	5/31/1998 9:20:00 PM
From: Anthony Wong	Respond to of 1722

Impotence May Be Early Sign of Heart Disease, Study Says Bloomberg News May 31, 1998, 11:44 a.m. PT Impotence May Be Early Sign of Heart Disease, Study Says San Diego, May 31 (Bloomberg) -- Men treated for impotence should undergo a full medical examination to see if the trouble is a symptom of heart disease or another life-threatening disorder, medical researchers said. In a new study of 42 men age 35 to 55, Loyola University Medical Center researcher John Mulhall found those with impotence caused by problems with blood flow to the penis were more likely to shown abnormalities when given a stress test by a cardiologist, even though they had no other signs of heart disease. Mulhall presented the research at the annual meeting of the American Urological Association in San Diego. ''We already know that impotence can be the first sign of diabetes, kidney failure or neurological diseases,'' Mulhall said. ''The new findings of a link between impotence and heart disease provide another import reason why men should undergo a thorough health examination rather than simply take measures or medications like Viagra to treat the impotence.'' Pfizer Inc.'s Viagra became one of the best-selling U.S. drugs within weeks of its April introduction. Analysts estimate sales in the first 12 months could top $1 billion. --Jim Finkle in San Diego through the Princeton newsroom

To: Anthony Wong who wrote (131)	5/31/1998 9:22:00 PM
From: Anthony Wong	Respond to of 1722

Heart, Diabetes Drugs May Someday Treat Impotence, Paper Says Bloomberg News May 31, 1998, 11:44 a.m. PT Newark, New Jersey, May 31 (Bloomberg) -- Drugs that treat high blood pressure and diabetes someday may be used as antidotes to impotence, which is often seen in older men with those medical conditions, the Newark Star-Ledger reported. Researchers are in early testing of this possible use of high blood pressure pills and an unidentified diabetes medicine and no one predicts yet that expanding use of these medicines will slow sales of Pfizer Inc.'s impotence pill, Viagra. One researcher appears to be looking at treating impotence by using a class of high blood pressure medicine that includes Bristol-Myers Squibb Co.'s Avapro, Novartis AG's Diovan and Merck & Co.'s Cozaar and Hyzaar, the paper said. Viagra became one of the best-selling U.S. drugs within weeks of its April introduction and is expected to have more than $1 billion in sales in its first 12 months on the market. (SL 5/31 A1 www.njnews.com) --Kerry Dooley in the Princeton newsroom (609) 279-4016/shw

To: Anthony Wong who wrote (131)	5/31/1998 9:26:00 PM
From: Anthony Wong	Read Replies (1) \| Respond to of 1722

Bicycle seats linked to impotence Sunday May 31 9:54 PM EDT By ED SUSMAN UPI Science News SAN DIEGO, May 31 (UPI) - Boston University researchers say that narrow, hard bicycle seats can cause impotence in men and sexual and urinary problems in women. In the first study comparing bicyclists to other athletes, the researchers find the incidence of impotence to be four times higher in the bicyclists than in a similar group of runners; women bicyclists reported higher incidence of clitoris dysfunction compared to female runners. The data was presented today at the annual meeting of the American Urological Association in San Diego. Dr. Irwin Goldstein, professor of urology at Boston University School of Medicine, says that while just 4 percent of men report impotence that can be attributed to their bicycle riding, there are 20 million recreation bicyclists. Goldstein, who has been researching bicycle-related impotence for four years, says, ''That means as many as 500,000 men are being made impotent from bicycle seats.'' Dr. Anthony Atala of Children's Hospital and Harvard Medical School, Boston, says, ''Dr. Goldstein's group may certainly be on to something with their studies. Their data does suggest there may be a connection between bicycle seats and impotence and other injuries.'' Goldstein and colleagues have demonstrated how rigid, narrow seats often used by long distance and competitive cyclists put pressure on blood vessels and nerves in the perineum (the area between the anus and vulva in women; between the anus and scrotum in men). He said, ''With increasing levels of bicycle riding exposure, males were found to have significantly more urologic complaints, including moderate to severe impotence, difficulty achieving orgasm, changes in ejaculatory sensation, difficulty urinating, chronic numbness and pain.'' Women also reported difficulty in achieving orgasm, difficulty urinating, clitoral numbness or pain. Copyright 1998 by United Press International.